Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Editorial Commentaries

Ionotropic Stress and Integrin

Another Link to Myocardial Remodeling

Saraswati Pokharel, Umesh C. Sharma
Download PDF
https://doi.org/10.1161/01.HYP.0000258702.03099.37
Hypertension. 2007;49:767-768
Originally published March 21, 2007
Saraswati Pokharel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Umesh C. Sharma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Cardiac remodeling is an adaptive response to chronically increased wall stress. Adaptive remodeling of the myocardium, caused either by increased workload or ionotropic stress, requires mediators for the communication of cardiac cells with their surrounding extracellular matrix.1 Integrins are likely candidates that transduce increased mechanical force into the intracellular biochemical signals. In this issue of Hypertension, Krishnamurthy et al2 report a potential role of myocardial β1-integrin in the adaptive and maladaptive remodeling that occurs in isoproterenol-induced left ventricular hypertrophy. To place the findings of this study in context with emerging studies regarding myocardial remodeling and the progression to left ventricular failure, a brief review of the biology of β1-integrin with respect to myocardial hypertrophy and remodeling is presented here.

Integrins are heterodimeric cell-surface receptors composed of α and β subunits that function as adhesive and signaling molecules, as well as mechanotransducers.3 In noncardiac cells, it has been demonstrated that integrins respond to abnormal strain in a manner similar to that which would be found during pressure or volume overload in the heart.4 Integrins are expressed in various types of cells, including leukocytes, endothelial cells, vascular smooth muscle cells, fibroblasts, and myocytes. Previously, integrins were considered as the structural protein essential for maintaining the integrity of the cell–matrix interaction.3 Emerging studies have established the role of integrins in signal transduction cascades involved in cell migration, proliferation, and growth. β1-Integrin is a dominant subunit expressed in the heart, which is shown to participate in the hypertrophic response of cardiac ventricular myocytes.5

The study by Krishnamurthy et al2 provides some unique insights into the potential role of integrin in left ventricular remodeling and function. This study used β-adrenergic stimulus to induce cardiac stress in wild-type and β1-integrin–deficient mice and examined β1-integrin function with respect to left ventricular remodeling and failure. In integrin-deficient mice, β-adrenergic receptor stimulation failed to increase myocardial fractional shortening and ejection fraction. These findings were associated with increased cardiomyocyte apoptosis. It is often speculated that progressive deterioration of left ventricular function in heart failure is because of ongoing loss of viable cardiomyocytes. Although these findings created considerable enthusiasm, some skepticism still remains as to whether cardiomyocyte apoptosis plays an important role in the progression of heart failure.

The data presented by Krishnamurthy et al2 regarding the putative role of β1-integrin in left ventricular remodeling and function are provocative in several ways. First, increased levels of β1-integrin were identified in mice after β-adrenergic receptor stimulation. Second, β1-integrin–deficient mice that received isoproterenol infusion for 4 weeks had higher levels of matrix metalloproteinase-2 and matrix metalloproteinase-9. Earlier, these investigators have demonstrated that matrix metalloproteinase-2 interferes with the phosphorylation of focal adhesion kinase that mediates survival signals of β1-integrin and activates c-Jun N-terminal kinase–dependent myocyte apoptosis.6 Activation of c-Jun N-terminal kinase is suggested to play a role in the activation of the mitochondrial death pathway of apoptosis in cells of cardiac and noncardiac origin.7,8 The authors observed greater increase in c-Jun N-terminal kinase activation in β1-integrin–deficient mice after isoproterenol infusion.2 Taken together, these studies suggest that increased matrix metalloproteinase-2 expression and activity may induce cardiac myocyte apoptosis in β1-integrin–deficient mice via the involvement of the c-Jun N-terminal kinase–dependent mitochondrial pathway.

In addition to their antiapoptotic effects, integrins are shown to mediate stretch-dependent matricellular response in chronic pressure overload. Integrins associate with signaling molecules in the focal adhesion complex, which act both as a signaling device and a connection to cytoskeleton.9,10 On stimulation, integrins interact with transducing molecules like P125 focal adhesion kinase, of which the amino-terminal domain binds to the intracellular domain of the β1- and β3-integrins, whereas its carboxyterminal binds to the SH2 and SH3 domains of several proteins involved in focal adhesion assembly and signal transduction. Ionotropic stress or mechanical stretch leads to the activation of the integrin-linked focal adhesion complex and phosphorylation of focal adhesion kinase at various tyrosine residues.9,10 Phosphorylation of focal adhesion kinase activates the c-Src signaling system and induces the production of connective tissue growth factor, which promotes ECM synthesis.11 This signal transduction mechanism has been implicated in the matricellular response to mechanical stretch. Therefore, the critical role of integrin in the cardiac remodeling processes is becoming recognized, and a simplified summary of some of the important pathways involved in integrin signaling is shown in the Figure.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Schematic diagram to show how β1-integrin can influence cell apoptosis and extracellular matrix (ECM) turnover. β-Adrenergic receptor (β-AR) stimulates the production of β1-integrin and matrix metalloproteinase-2 (MMP-2). Ionotropic stress or mechanical stretch activates integrin-linked focal adhesion complex and phosphorylates focal adhesion kinase (FAK) at various tyrosine residues. Phosphorylated focal adhesion kinase (P-FAK) blocks the phosphorylation of c-Jun N-terminal kinase (JNK), leading to the inhibition of mitochondrial death pathway and myocyte apoptosis. P-FAK also activates c-Src signaling system and increases the transcription of connective tissue growth factor, which promotes ECM synthesis. In addition, β-AR–mediated production of MMP-2 inhibits FAK phosphorylation leading to reversal of integrin-induced antiapoptotic and profibrotic signaling events. β1-I indicates β1-integrin; CTGF, connective tissue growth factor.

Although these studies are associative, they do emphasize a protective role of β1-integrins in β-adrenergic receptor–stimulated apoptosis and adverse cardiac remodeling. These findings suggest that integrin is important for physiologically “intact” β-adrenergic receptor–induced cardiac load and injury in cardiomyocytes and fibroblasts. As suggested by the authors, further research to elucidate the mechanisms that shift the balance from apoptosis to cell survival during chronic β-adrenergic stimulation may have important clinical implications to counteract the detrimental effects of chronic adrenergic overstimulation.

Acknowledgments

Source of Funding

U.C.S. is a recipient of the American Heart Association Greater Mid-West Fellowship (2006).

Disclosures

None.

Footnotes

  • The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.

References

  1. ↵
    Ross RS. The extracellular connections: the role of integrins in myocardial remodeling. J Card Fail. 2002; 8: S326–S331.
    OpenUrlCrossRefPubMed
  2. ↵
    Krishnamurthy P, Subramanian V, Singh M, Singh K. Beta1 integrins modulate beta-adrenergic receptor–stimulated cardiac myocyte apoptosis and myocardial remodeling. Hypertension. 2007; 49: 865–872.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Ingber D. Integrins as mechanochemical transducers. Curr Opin Cell Biol. 1991; 3: 841–848.
    OpenUrlCrossRefPubMed
  4. ↵
    Shyy JY, Chien S. Role of integrins in cellular responses to mechanical stress and adhesion. Curr Opin Cell Biol. 1997; 9: 707–713.
    OpenUrlCrossRefPubMed
  5. ↵
    Ross RS, Pham C, Shai SY, Goldhaber JI, Fenczik C, Glembotski CC, Ginsberg MH, Loftus JC. Beta1 integrins participate in the hypertrophic response of rat ventricular myocytes. Circ Res. 1998; 82: 1160–1172.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Menon B, Krishnamurthy P, Kaverina E, Johnson JN, Ross RS, Singh M, Singh K. Expression of the cytoplasmic domain of beta1 integrin induces apoptosis in adult rat ventricular myocytes (ARVM) via the involvement of caspase-8 and mitochondrial death pathway. Basic Res Cardiol. 2006; 101: 485–493.
    OpenUrlCrossRefPubMed
  7. ↵
    Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995; 270: 1326–1331.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996; 380: 75–79.
    OpenUrlCrossRefPubMed
  9. ↵
    MacKenna DA, Dolfi F, Vuori K, Ruoslahti E. Extracellular signal-regulated kinase and c-Jun NH2-terminal kinase activation by mechanical stretch is integrin-dependent and matrix-specific in rat cardiac fibroblasts. J Clin Investig. 1998; 101: 301–310.
    OpenUrlPubMed
  10. ↵
    Zhang S, Weinheimer C, Courtois M, Kovacs A, Zhang CE, Cheng AM, Wang Y, Muslin AJ. The role of the Grb2-p38 MAPK signaling pathway in cardiac hypertrophy and fibrosis. J Clin Investig. 2003; 111: 833–841.
    OpenUrlCrossRefPubMed
  11. ↵
    Graness A, Cicha I, Goppelt-Struebe M. Contribution of Src-FAK signaling to the induction of connective tissue growth factor in renal fibroblasts. Kidney Int. 2006; 69: 1341–1349.
    OpenUrlPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
April 2007, Volume 49, Issue 4
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Ionotropic Stress and Integrin
    Saraswati Pokharel and Umesh C. Sharma
    Hypertension. 2007;49:767-768, originally published March 21, 2007
    https://doi.org/10.1161/01.HYP.0000258702.03099.37

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Ionotropic Stress and Integrin
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Ionotropic Stress and Integrin
    Saraswati Pokharel and Umesh C. Sharma
    Hypertension. 2007;49:767-768, originally published March 21, 2007
    https://doi.org/10.1161/01.HYP.0000258702.03099.37
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Basic, Translational, and Clinical Research
    • Contractile Function
    • Cell Signaling/Signal Transduction
  • Heart Failure and Cardiac Disease
    • Hypertrophy
    • Remodeling
    • Cardiorenal Syndrome

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured